Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
₹ 366.05
Key Takeaways
Risk factor
Very poor trading liquidity
Data is available to registered users only
Data is available to registered users only
Profitability factor
Very strong margins and returns
Data is available to registered users only
Data is available to registered users only
About
BDH Industries Ltd. engages in the manufacturing of therapeutic formulations. It products include, fentanyl citrate injection usp, acetaminophen oral solution usp, paracetamol tablets, paracetamol injection, benzyl benzoate application, praziquantel, mebendazole, thioridazine oral solution, thioridazine tablets and haloperidol injection. The company was founded in 1935 and is headquartered in Mumbai, India.
Company Valuation
Considering past and projected metrics, the stock is neither 'expensive' nor 'cheap' compared to its peers. In particular, the stock is reasonably priced on P/E, of fair
Data is available to registered users only
Buy
Sell